Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 1 2Phase 2 1

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Other hematologic neoplasm 1Gynecologic 1CNS 1

Conditions

Ovarian High Grade Serous Adenocarcinoma 1Medulloblastoma 1Locally Advanced Non-Small Cell Lung Cancer 1Leukemia, Myeloid, Acute 1Hypoxia 1Glioma 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Atovaquone × Clear all
NCT04648033 2026-01-29

ARCADIAN

University of Oxford

Phase 1 Completed
21 enrolled 21 charts
Thoracic

Locally Advanced Non-Small Cell Lung Cancer

NCT03568994 2026-01-27

ATACC AML

Baylor College of Medicine

Phase EARLY_PHASE1 Completed
26 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05998135 2025-09-11

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Emory University

Phase 2 Recruiting
28 enrolled
Gynecologic

Ovarian High Grade Serous Adenocarcinoma

NCT06624371 2025-07-22

AflacBT2303

Emory University

Phase 1 Recruiting
18 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

NCT02628080 2019-09-04

ATOM

University of Oxford

Phase EARLY_PHASE1 Completed
46 enrolled
Thoracic

Hypoxia, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡